(Q51091390)

29 March 2018

title

CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. (English)

1 reference

29 March 2018

author name string

Jerabek I

1

1 reference

29 March 2018

Boulenger JP

2

1 reference

29 March 2018

Bradwejn J

3

1 reference

29 March 2018

Lavallée YJ

4

1 reference

29 March 2018

Jolicoeur FB

5

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 March 2018

European Neuropsychopharmacology

published in

1 reference

29 March 2018

volume

9

1 reference

29 March 2018

page(s)

149-155

1 reference

29 March 2018

issue

1-2

1 reference

29 March 2018

Vagal attenuation in panic disorder: an assessment of parasympathetic nervous system function and subjective reactivity to respiratory manipulations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

The cholecystokinin hypothesis of anxiety and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Increased anxiogenic effects of caffeine in panic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Lactate infusions: the role of baseline anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Measurement of lactate-induced panic and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Interoception and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Ambulatory monitoring of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. A possible mechanism of panic provocation?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Ventilatory physiology of patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Psychophysiological response patterns in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Phobic anxiety in panic disorder: Cognition, heart rate, and subjective anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Lactate provocation of panic attacks. II. Biochemical and physiological findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Endocrine and cardiovascular responses during phobic anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Cognitive mediation in the affective component of spontaneous panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Stress test reactivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Cognitive, social, and physiological determinants of emotional state.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Ambulatory heart rate changes in patients with panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Panic symptoms after inhalation of carbon dioxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Cognitive determinants of lactate-induced anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Situational panic attacks. Behavioral, physiologic, and biochemical characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

Lactate infusions in panic disorder patients and normal controls: autonomic measures and subjective anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900020-0

7 January 2021

10.1016/S0924-977X(98)00020-0

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

10082241

1 reference

29 March 2018